Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Anakinra  Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022 57 5
Dexamethasone Emergency use authorization Used to treat other disease Other treatment Jan/21/2022 16 1
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Nov/03/2021 41 4
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Arbidol Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/03/2021 14 3
Dobutamine Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/24/2021 2 0
Fenoterol Potential treatment - theoretical effect Used to treat other disease Antiviral Feb/20/2021 4 0
Lianhua Qingwen Recommended by China's NHC Guidelines Natural product Other treatment Jan/29/2021 3 0
Methylene blue Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/13/2021 2 0